insights_auto
Why is ALLO down 2.05%?
Dive Deeperchevron_right
ALLO:NASDAQ
Allogene Therapeutics Inc
$1.43
arrow_downward
-2.05%(-0.030) 1D
$1.45
arrow_upward
+1.40% (+0.020)bedtimeAfter hours
Closed: Oct 7, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALLO...
Open
$1.46
High
$1.47
Low
$1.42
Mkt. cap
494.05M
Avg. vol.
5.48M
Volume
3.90M
52-wk high
$4.46
52-wk low
$1.04
EPS
-$0.67
Beta
0.56
Shares outstanding
345.49M
No. of employees
150
Open
$1.46
High
$1.47
Low
$1.42
Mkt. cap
494.05M
Avg. vol.
5.48M
Volume
3.90M
52-wk high
$4.46
52-wk low
$1.04
EPS
-$0.67
Beta
0.56
Shares outstanding
345.49M
No. of employees
150
News stories
From web sources and news partners
Simply Wall Street
·
25 minutes ago
Powell Industries (POWL) Could Be 41% Undervalued As LNG And Data Center Demand Builds
MarketBeat
·
23 minutes ago
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells $27,909.60 in Stock
Yahoo Finance
·
7 hours ago
These 7 major S&P 500 stocks need to rally at least 200% to reclaim their peaks
The Motley Fool
·
1 hour ago
The S&P 500 Just Reached a New Record. Here’s What History Says About Buying Stocks Now.
About Allogene Therapeutics Inc
CEO-
Employees150
Founded2017
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteallogene.com